SUMMARY
Two novel antimicrobial peptides named theromacin and theromyzin, were isolated and characterized from the coelomic liquid of the leech, Theromyzon tessulatum. Theromacin is a 75 amino acid cationic peptide containing 10 cysteine residues arranged in a disulfide array showing no similarities with other known antimicrobial peptides. Theromyzin is an 86 amino acid linear peptide and constitutes the first anionic antimicrobial peptide observed in invertebrates. Both peptides exhibit an activity directed against Gram positive bacteria.
Theromacin and theromyzin cDNAs code precursor molecules containing a putative signal sequence directly followed by the mature peptide. Enhancement of theromacin and theromyzin mRNA levels has been observed after blood meal ingestion and upon bacterial challenge. In situ hybridization revealed that both genes are expressed in large fat cells in contact with coelomic cavities. Gene products were immunodetected in large fat cells, in intestinal epithelia and at the epidermis level. In addition, a rapid release of the peptides into the coelomic liquid was observed after bacteria challenge. The presence of antimicrobial peptide genes in leeches and their expression in a specific tissue, functionally resembling the insect fat body, evidence for the first time an antibacterial response in a lophotrochozoan comparable to that of holometabol insects.
INTRODUCTION
All multicellular organisms including plants, invertebrates and vertebrates have developed an immediate response to defend themselves against infectious microorganisms (1) (2) . Recent studies on the components of the innate immune system have demonstrated the contribution of antimicrobial peptides to the host defense. Antibiotic peptides are small molecules. Basis on their structural features, three classes were defined : 1/ linear α helical peptides without cysteines, the prototype of this family are the cecropins ; 2/ open-ended cyclic cysteine-rich peptides among which defensins are the most widespread and 3/ linear peptides containing a high proportion of one or two amino acids like indolicidin (3) . In spite of great primary structure diversity, the majority of antimicrobial peptides documented are characterized by a preponderance of cationic and hydrophobic amino acids. This amphipathic structure allows them to interact with bacterial membrane. Brogden et al have determined in ovine that a novel class of peptides with anionic properties also has antimicrobial properties (4) . In marked contrast to cationic antimicrobial peptides, no anionic antibacterial molecules, has been hitherto described in invertebrates.
Antimicrobial peptides appear to be essential anti-infectious factors that have been conserved during evolution. Meanwhile, their implications in immune processes are different according to species, cells and tissues (5) . The involvement of antimicrobial peptides in natural resistance to infection is sustained by their strategic location in phagocytes, in body fluids and at epithelial level i.e. at interfaces between organisms and its environment. This action is strengthened by the rapid induction of such antibacterial peptide genes in bacteria challenged plants or animals. Drosophila melanogaster submitted to a septic injury, massively induces and synthesizes a battery of potent antibiotic molecules from fat body, a functional equivalent of the mammalian liver (6) . Active peptides are then released into the hemolymph where they exert their antifungal and/or antibacterial activities. Adding to their systemic response, antibiotic molecules of the fruit fly are produced by cells of most of the barrier epithelia such tracheal epithelium, gut lining or salivary glands, where they provide a local first defense against microorganisms (7) (8) .
In worms, even if antimicrobial activities have been detected in the body fluids of several species, antimicrobial peptides have been fully characterized in nematods and annelids only. A 71 amino acid peptide named ASABF (for Ascaris suum antibacterial factor) possessing structural and functional similarities to the insect/arthropod defensins, has been characterized in the parasitic nematode A. suum (9) . Recently Pillai et al showed an enhancement of the ASABF transcript in the body wall upon bacteria challenge (10) .
ASABF presents significant sequence identity with peptides deduced from a cDNA sequence (yk150c7) and from a putative gene (T22H6.5) of the free-living nematode, Caenorhabditis elegans. Although no variation of the C.elegans ASABF gene expression was detected using high density cDNA microarrays, Mallo et al demonstrated that Gram negative bacteria infection of this worm provokes a marked upregulation of genes encoding lysozyme and lectins, known to be involved in immune responses of other species. These authors also established that certain infection inducible genes are under the control of the DBL/TGFβ pathway (11) . The existence of an inducible immune system in both nematodes and insects is consistent with the new molecule-based phylogeny which considers that protostomes can be divided into two large groups: ecdysozoans comprising nematods, arthropods and other phyla emerged and lophotrochozoans regrouping annelids, flat worms, mollusks (12)… In lophotrochozoans, no inducible antimicrobial peptides have been so far described in studied animals. Gene encoding lumbricin I, a proline-rich antibacterial peptide from the earthworm, Lumbricus rubellus, is constitutively expressed (13) . Constitutive expression has also been reported in the mussel Mytilus galloprovincialis in which, antibiotic peptides stored in hemocyte granules are released after bacteria challenge (14) . In the present study, we report the primary and secondary structure of two new antibacterial peptides, theromacin and theromyzin, isolated from the body fluid of an annelid: the leech T. tessulatum. Interestingly both molecules do not present significant similarities with other known molecules: theromacin is a novel cystein rich antimicrobial peptide and theromyzin constitutes a new anionic antibiotic peptide. In an experimental model of infection, we obtained evidence for an enhancement of transcription levels of both genes in specific tissues which could be assimilated to the fat body of D. melanogaster. We have found that peptides are massively released into hemolymph where they might exert their antimicrobial activity by a systemic action. These data reminiscent of the drosophila antimicrobial defense, are the first reports of antimicrobial peptide induction by a specific tissue in a lophotrochozoan.
EXPERIMENTAL PROCEDURES

Animals
Theromyzon tessulatum rhynchobdellid leech is an ectoparasite of aquatic birds. Its life cycle is subdivided in stages defined by taking, as indicators, the 3 blood meals (stage 0, from hatching till the first blood meal; stages 1-2-3, after, respectively, first, second and third blood meal). The stage 3 corresponds to the gametogenesis phase.
Theromacin and theromyzin purification procedure
Stage 3 animals were individually pricked with saline solution or with 10µl of a solution containing 10 9 killed E. coli (D31). Coelomic fluid and mucus recovering the animals were collected, with a tuberculin syringe at t=0, t=3 h. and t=24 h after challenge. Liquids were immediately centrifuged at 800 g for 15 min at 4°C and supernatants were diluted (1:1 v/v) in pure water (Beckman) containing 0.1% of trifluoroacetic acid (TFA). The pH was brought to 3.9 with 1 M HCl. Centrifugation (10000 g, 20 min, at 4°C) was then used to clarify the supernatants, which were loaded onto Sep-Pak C18 Vac cartridges (Waters™) according to Bulet et al. Elution steps were performed with 5% and 40% acetonitril (ACN) in acidified water. The prepurified fractions were then concentrated, reconstituted in pure water and tested for antimicrobial activity as described below. Only the 40% ACN eluted fractions were active and submitted to purification by reversed-phase HPLC (RP-HPLC). All the following HPLC steps were carried out on a Beckman™ Gold HPLC system.
Step 1: Aliquots of the 40% Sep-Pak fractions were subjected to RP-HPLC on a Sephasyl C18 column (250 x 4.1 mm, 218TP54 Vydac™). Elution was performed with a linear gradient of 2-52 % ACN in acidified water over 90 min at a flow rate of 1 ml/min. Fractions corresponding to absorbance peaks were collected in polypropylene tubes, dried, reconstituted in water and tested for antimicrobial activity.
Step 2: Active fractions were further loaded onto a C18 column (250 x 2.1 mm, 218TP52
Vydac™) with a gradient consisting in 2-25% ACN in acidified water for 10 min and 25-35% ACN for 40 min. at a flow rate of 0.2 ml/min. Fractions were collected and treated as above.
Step 3: One additional step was performed on a narrowbore C18 reversed phase column (150 x 2 mm, Waters™) at a flow rate of 0.2 ml/min using the ACN gradient described in the step 2.
The purity assessment and the molecular weight determination of theromacin and theromyzin were carried out by mass spectrometry in electrospray positive ion mode using 
Bioassays
-Microorganisms: The bacteria E. coli D31, Micrococcus luteus IFO12708 and the filamentous fungus Fusarium oxysporum were used for the antimicrobial assays.
-Antimicrobial tests: After each purification step, antibacterial activity was monitored by a liquid growth inhibition assay as described by Bulet et al (15) . The minimal inhibitory concentration (MIC) and the minimal bactericidal concentration (MBC) was determined according to the method of Hancock (16) . Antifungal activity was monitored as described by
Felhbaum et al by a liquid growth inhibition assay (17).
-Bactericidal test was performed as previously described (18) . parameters were identical to those described in step 1. All PCR products were sub-cloned into pGEM-T easy vector (Promega) and several different cDNA clones were sequenced.
Gene expression site
-In situ hybridization: Leeches were fixed overnight in a solution containing 13% formalin, 39% ethanol and 0.65% ammonium hydroxide, pH 6.4. After dehydration, animals were embedded in paraplast and 7 µm sections were cut, mounted on poly-L-lysine coated slides and stored at 4°C until use.
Plasmids containing the coding region of theromacin and theromyzin probes were used as templates for the synthesis of the probes. Digoxigenin (DIG)-UTP-labeled and 35 S-UTPlabelled antisense and sense riboprobes were generated from linearized cDNA plasmids by in vitro transcription using RNA-labeling-kit (Roche). DIG-labeled riboprobes (40-100 ng per slide) and 35 S-labeled riboprobes (100 ng or 1x10 6 cpm/slide) were hybridized as previously described (19) . Slides were observed under a Zeiss Axioskop microscope.
Control consisted in replacing antisense riboprobe with sense riboprobe. RNase control sections were obtained by adding a pre-incubation step with 10 µg/ml RNaseA prior to hybridization.
Gene expression analysis
-Northern blot: Leeches were homogenized in Trizol using a polytron. Total RNA was extracted according to the manufacturer's protocol (Life Technologies). 10 µg of total RNAs and size markers were separated on a 1 % agarose gel electrophoresis containing 0.02 membrane (Amersham). Theromacin and theromyzin probes were synthesized from the 332 pb fragment and the 405 pb fragment amplified in the first PCR respectively (see above). An 18S subunit probe was also performed as control. A sense oligonucleotide 5'-GCGGGAACGAGCGCGCGTTTATTAGAT-3' and an antisense oligonucleotide 5'-TGGCACCAGACTTGCCCTCCAATT-3' were designed from the ribosomal RNA 18S
subunit of Theromyzon tessulatum (Genbank accession number: AFO99942), and used in PCR experiments before being sub-cloned into pGEM T easy vector. Plasmids containing theromacin cDNA or 18S cDNA were digested with EcoRI and inserts were purified from 1% agarose gel using the Wizard PCR preps DNA purification system (Promega). Twentyfive ng of each fragments were then 32 P labeled by random priming using the Ready-to-go DNA labeling kit (Pharmacia). Hybridization and detection were performed as previously described.
-In Situ Hybridization: Quantification of the radiolabeling at the cellular level was performed using an Axiophot Zeiss microscope and a Biocom quantification system as established (20) . immunostainings were performed using a gold-tagged secondary antibody and silver amplification as described above.
Controls were incubations of immunserum pre-adsorbed by synthetic peptides.
Variation of plasmatic amount
Aliquots of 40 % ACN Sep-Pak and beta-lactoglobulin (Applied biosystems) at different concentration (250, 375 and 500 pmol) were subjected to RP-HPLC on a C18 column (250 x 4.1 mm, 218TP54 Vydac). Elution was performed as described above. Area of peak corresponding to theromacin or theromyzin was calculated and amount peptide was evaluated by comparing the values with the beta-lactoglobulin standard. Obtained amount divided by the volume of initially collected hemolymph allowed to estimate the concentration of theromacin in the coelomic fluid of the leech.
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Theromacin and theromyzin were isolated from leech body fluid in acidic conditions (Fig.1) .
A 30 residue NH2-terminal sequence of the purified molecules was then obtained by automatic Edman degradation. In parallel, electrospray and MALDI TOF mass spectrometry analysis revealed a deduced molecular mass of 8,517.98 Da for theromacin and 9,973.1 Da for theromyzin illustrating that the sequences obtained by Edman degradation were incomplete (Fig 1) .
To fully determine the amino acid sequences of the peptides and to obtain information on the precursors, cDNA cloning was carried out using a two step PCR based approach (see materials and methods and The difference in mass was attributable to the arrangement of the 10 cysteine residues contained in the sequence in five disulfide intramolecular bridges.
In contrast with theromacin, the calculated mass of theromyzin was in perfect agreement with the measured mass demonstrating that theromyzin is a peptide devoid of posttranslational modifications.
Precursor sequences were also deduced from the cDNA sequences (Fig.2) . Signal PVI software analysis revealed that (1) theromacin and theromyzin are flanked at the N terminus by a putative hydrophobic signal peptide : Met 1 -Ala 22 and Met 1 -Ala 21 respectively (2) the cleavage site for signal peptidase is most likely located after the Ala 22 preceding the Gly 23 for theromacin and after the Ala 21 preceding the Asp 22 for theromyzin. This leads to the notion that mature peptides may be generated through conventional processing mechanisms and can be secreted to the extracellular medium.
Determination of the disulfide array of theromacin
In order to decipher the pattern of the cysteine residues engaged in disulfide bridges, the molecular mass of theromacin was first subjected to alkylation with acrylamid then measured by MALDI-TOF mass spectrometry. The mass spectrum revealed that reducing the protein prior to the alkylation step lead to a mass shift of 710.37 Da, consistent with the incorporation of 10 acrylamid molecules, whereas alkylation alone did not (data not shown).
This result demonstrates that the 10 cysteine residues of theromacin are engaged in five disulfide bridges. Analysis of the primary structure of the antibacterial peptide showing that theromacin did not harbor a cysteine motif described in other known antimicrobial peptides, determination of the disulfide array was visualized by protease digestion of the native peptide ( Fig 3A) .
The peptidic fragments resulting from the lysyl endopeptidase digest were analyzed by MALDI-TOF-MS. As illustrated in figure 3 (9) which does not present any similarities with those determined in other peptides or proteins. Theromacin is consequently a novel cysteine-rich antimicrobial peptide.
Biological activity of theromacin and theromyzin
In liquid growth inhibition assay, the purified theromacin was active against M. luteus (MIC nM, a concentration 10 times higher than the MIC value, all the bacteria were killed in less than 5h (Fig.4) . Consequently, theromacin exerts a bactericidal activity. Loss of antibacterial property was noticed when theromacin was reduced demonstrating that disulfide bridges play an important role in the biological activity of the molecule. Theromyzin was shown to be active against M. luteus (MIC 250-500 nM). Growth of bacteria on the plate was observed when theromyzin was tested for the MBC determination showing that the molecule possesses a bacteriostastic activity against M. luteus.
Expression and induction of theromacin and theromyzin transcripts
Gene expression pattern of theromacin and theromyzin during immune response was investigated by Northern blot. Analysis of RNA level in stage 3 leeches was first assessed 0, To corroborate these results and to better understand physiological role of theromacin and theromyzin in stage 3 leeches, we investigated the localization of the gene expression site using ISH (Fig. 5B, 6A ). By contrast to stage 3 animals (Fig. 5A) , no RNA baseline level (theromacin) or very few (theromyzin) was observed in stage 2 leeches (Fig. 6A) . Highest sensitivity of the ISH compared to Northern blot could explain why theromyzin transcripts were detected in the control by this technique only.
Thus, we hypothesized that several physiologic event which occurred during the transition stage 2/stage 3 may be inducers of theromacin and theromyzin genes expression. In support of this hypothesis, stage 2 leeches were collected 24h, 48h and 72h after the blood meal, which corresponds to the tripping factor of the transition. Total RNAs of stage 3 leeches were extracted and probed with the theromacin and theromyzin cDNA successively. Results presented in figure 6B , underlined a low but progressive increase of both theromacin and theromyzin transcripts after the blood meal confirming our hypothesis.
These results define the cells implicated in the theromacin and the theromyzin mRNA synthesis. We concluded that in all cases of induction i.e. bacteria, saline injections or transition stage 2/stage3, the enhancement of theromacin and theromyzin transcripts were observed only in LFC. This suggests that the leech LFC may constitute an organ implicated in the synthesis of antimicrobial molecules, comparable to the insect fat body.
Immune localization of theromyzin and theromacin peptides and dynamic of their release in the body fluid
To specify the participation of theromacin and theromyzin in anti-infectious processes immunocytochemical and plasmatic titration procedures were carried out in leeches subjected to bacterial challenge. Theromacin and theromyzin storing sites were investigated by immunocytochemistry on sections of unchallenged leeches (Fig. 7) . Theromacin immunoreactivity was found in LFC (Fig. 7A) , in the intestinal epithelium (IE) (Fig. 7B) and at the epidermis level (Ep). Theromyzin immunolabeling was also observed in LFC (Fig.   7F ). Semi-thin sections confirmed the labeling of LFC and showed a strong immunoreactivity in coelomic cavities (CC) in contact with the LFC when using theromacin (Fig. 7E) and theromyzin (Fig. 7F, 7G ) antisera. No immunolabeling was detected in the controls (Fig. 7D, 7H ) confirming the specificity of the reaction. Interestingly, these coelomic cavities contain the body fluid from which theromacin and theromyzin were isolated. These results argue in favor of an exocytosis of the antibacterial peptides from the LFC to the body fluid of the leech.
To study the effect of injury on exocytosis mechanism, variation of theromacin and 
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